BlueRock Therapeutics reports positive 36-month results from phase I trial of bemdaneprocel for treating Parkinson’s disease: Berlin, Germany Wednesday, October 8, 2025, 18:00 H ...
We're rounding up all the best health, fitness, beauty, parenting and tech deals you don't want to miss this Prime Day – ...